date:Nov 08, 2013
eets the FDA's criteria for safety. To ensure even greater confidence in its ingredients, Morinaga said that it has submitted its safety dossiers to the U.S. FDA for review, which has resulted in these two Letters of No Objection.
In 2009, Morinaga achieved GRAS status for its first flagship probiotic ingredient, Bifidobacterium longum BB536, which it claims is one of the best-selling probiotics in Japan.
A GRAS determination for an ingredient intended for use in infant formula requires the ut